Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms responsible for cardiac and skeletal muscle energetic impairment in type 1 diabetes
2006-002638-39Phase 2Unknown
- Sponsor
- University Hospitals Birmingham
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of piroxicam-beta-cyclodextrin in diabetes mellitus type 1 (T1D), sponsored by University Hospitals Birmingham. Primary endpoint: Change in cardiac PCr/ATP ratio. Status: unknown.
02
Drugs
piroxicam-beta-cyclodextrin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2006-002638-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002638-39.